Skip to main content
Zentiva S.A. logo

Zentiva S.A. — Investor Relations & Filings

Ticker · SCD ISIN · ROSCDBACNOR8 LEI · 254900HN31MYF870PE70 RO Manufacturing
Filings indexed 156 across all filing types
Latest filing 2023-03-20 AGM Information
Country RO Romania
Listing RO SCD

About Zentiva S.A.

https://www.zentiva.com/

Zentiva is an international pharmaceutical company that develops, manufactures, and delivers a wide range of high-quality, affordable medicines. The company's portfolio includes generic pharmaceuticals, over-the-counter (OTC) products, and biosimilars. Serving over 100 million people in more than 30 countries, Zentiva focuses on increasing patient access to essential treatments, primarily across Europe and other global markets. The company is committed to providing health and wellbeing solutions for all generations.

Recent filings

Filing Released Lang Actions
Raport curent de informare a investitorilor
AGM Information Classification · 99% confidence The document is explicitly titled "RAPORT CURENT" (Current Report) and details the resolutions passed during the Ordinary General Meeting of Shareholders (AGOA) and the Extraordinary General Meeting of Shareholders (AGEA) held on March 20, 2023. The content focuses entirely on the outcomes of these shareholder meetings, including the appointment of new board members and changes to the company's secondary activity code. This directly corresponds to the definition of reporting materials related to an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2023-03-20 Romanian
Schimbari in conducerea societatii comerciale - RC09
Board/Management Information Classification · 99% confidence The document is explicitly titled a "CURRENT REPORT" issued by ZENTIVA S.A. pursuant to Romanian regulations (Regulation no. 5/2018). The key event reported is the termination of a Board of Directors member's mandate and the appointment of a temporary replacement, effective February 10, 2023. This content directly relates to changes in the company's senior management and board structure. This aligns perfectly with the definition for Board/Management Information (MANG). It is not a full Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as the subject matter is highly specific to management changes.
2023-02-10 English
Raport Financiar Trimestrial - RFT
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly financial report for S.C. ZENTIVA S.A. for the period ending September 30, 2022. It contains detailed financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, Cash Flow Statement, and Statement of Changes in Equity, along with notes to the financial statements. Since it covers a period shorter than a full fiscal year and provides substantive financial data, it is classified as an Interim/Quarterly Report. 9M 2022
2022-11-15 English
Raport Financiar Trimestrial - RFT
Interim / Quarterly Report Classification · 100% confidence The document is a 'Raportare Contabila Trimestriala' (Quarterly Accounting Report) for S.C. ZENTIVA S.A. as of September 30, 2022. It contains comprehensive financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, Cash Flow Statement, and Statement of Changes in Equity, along with explanatory notes. Since it covers a period shorter than a full fiscal year (Q3 2022) and includes substantive financial data, it is classified as an Interim/Quarterly Report. 9M 2022
2022-11-15 Romanian
Raportare tranzactii parti afiliate in conformitate cu art.92 ind.3 din Legea 24/2017
Regulatory Filings Classification · 95% confidence The document is titled "RAPORT CURENT" (Current Report) and is addressed to the Romanian Financial Supervisory Authority (ASF) and the Bucharest Stock Exchange. It explicitly references Article 108 of Law 24/2017 regarding issuers of financial instruments and market operations. The content details transactions concluded with related parties (Zentiva Group a.s. and Zentiva k.s.) whose values exceeded the 5% threshold of the company's net assets, requiring disclosure under this specific regulation. This type of mandatory, periodic disclosure of significant related-party transactions, often triggered by specific thresholds defined in local securities law, fits best under the general category of Regulatory Filings (RNS) or potentially a specific type of disclosure if one existed. Given the provided definitions, RNS is the most appropriate fallback for a mandatory regulatory disclosure that isn't a standard financial report (10-K, IR) or a specific event like a dividend or management change. Since it is a detailed report of transactions, it is not merely an announcement of a report (RPA).
2022-06-14 Portuguese
Raport Financiar Anual - RFA
Annual Report
2022-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.